Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
NovoCure Limited Ordinary Shares
NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.
IPO Date: September 28, 2015
Sector: Healthcare
Industry: Medical Instruments and Supplies
Market Cap: $1.87B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.33 | 2.70%
Avg Daily Range (30 D): $0.40 | 2.31%
Avg Daily Range (90 D): $0.42 | 2.41%
Institutional Daily Volume
Avg Daily Volume: .77M
Avg Daily Volume (30 D): 1M
Avg Daily Volume (90 D): .86M
Trade Size
Avg Trade Size (Sh.): 72
Avg Trade Size (Sh.) (30 D): 61
Avg Trade Size (Sh.) (90 D): 59
Institutional Trades
Total Inst.Trades: 4,955
Avg Inst. Trade: $3.62M
Avg Inst. Trade (30 D): $2.66M
Avg Inst. Trade (90 D): $2.66M
Avg Inst. Trade Volume: .07M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $5.57M
Avg Closing Trade (30 D): $3.65M
Avg Closing Trade (90 D): $2.91M
Avg Closing Volume: 105.6K
   
News
Jul 24, 2025 @ 1:21 PM
Novocure: Steady Ahead of Key Milestones
Source: Lou Whiteman
Apr 24, 2025 @ 1:25 PM
NovoCure Surpasses Q1 Expectations
Source: Jesterai
Apr 16, 2025 @ 7:43 PM
Why NovoCure Stock Was Withering on Wednesday
Source: Eric Volkman
Dec 6, 2024 @ 1:32 PM
Why NovoCure Stock Was Winning Big This Week
Source: Eric Volkman
Sep 6, 2024 @ 9:19 PM
Why NovoCure Stock Dived by 13% This Week
Source: Eric Volkman
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $-1.51 $-.31 $-.28
Diluted EPS $-1.51 $-.31 $-.28
Revenue $ 621.71M $ 154.99M $ 155.1M
Gross Profit $ 479.7M $ 116.47M $ 119.72M
Net Income / Loss $ -164.19M $ -34.32M $ -30.57M
Operating Income / Loss $ -166.84M $ -37.87M $ -32.09M
Cost of Revenue $ 142.01M $ 38.52M $ 35.37M
Net Cash Flow $ -327.93M $ -36.66M $ 20.76M
PE Ratio